Clinical Trial Update: Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 trial comparing telbivudine alone versus the combination of telbivudine and valtrocitabine in chronic hepatitis B has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Telbivudine (telbivudine)
• Valtrocitabine (valtrocitabine)

Snippet

Sponsor: Novartis | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED